Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03142334
Brief Title: Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

First Submitted : May 3, 2017
First Submitted that Met QC Criteria : May 3, 2017
First Posted : May 5, 2017

Last Update Submitted that Met QC Criteria : May 16, 2019
Last Update Posted : May 17, 2019